Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 8/2018

01-08-2018 | Letter to the editor

Management of radiation-induced mucosal necrosis with photobiomodulation therapy

Authors: Caroline de Bataille, Vincent Sibaud, Angélique Prioul, Anne Laprie, Emmanuelle Vigarios

Published in: Supportive Care in Cancer | Issue 8/2018

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Epstein JB, Song PY, Ho AS, Larian B, Asher A, Bensadoun RJ (2017) Photobiomodulation therapy: management of mucosal necrosis of the oropharynx in previously treated head and neck cancer patients. Support Care Cancer 25:1031–1034CrossRefPubMed
2.
Elad S, Zadik Y (2016) Chronic oral mucositis after radiotherapy to the head and neck: a new insight. Support Care Cancer 24:4825–4830CrossRefPubMed
3.
Epstein JB, Raber-Durlacher JE, Lill M, Linhares YP, Chang J, Barasch A et al (2017) Photobiomodulation therapy in the management of chronic oral graft-versus-host disease. Support Care Cancer 25:357–364CrossRefPubMed
4.
Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S et al (2016) Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer 24:2781–2792CrossRefPubMedPubMedCentral
5.
Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR (2016) Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. Support Care Cancer 24:2793–2805CrossRefPubMedPubMedCentral
6.
Pereira AN, Eduardo Cde P, Matson E, Marques MM (2002) Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med 31:263–267CrossRefPubMed
7.
Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM et al (2014) MASCC=ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120:1453–1461CrossRefPubMedPubMedCentral
8.
Sonis ST, Hashemi S, Epstein JB, Nair RG, Raber-Durlacher JE (2016) Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients. Oral Oncol 54:7–14CrossRefPubMed
9.
Peterson DE, Boers-Doets CB, Bensadoun RJ, Herrstedt J, Guidelines Comittee ESMO (2015) Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol 26:v139–v151CrossRefPubMed
10.
Vigarios E, Epstein JB, Sibaud V (2017) Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support Care Cancer 25:1713–1739CrossRefPubMed
Metadata
Title
Management of radiation-induced mucosal necrosis with photobiomodulation therapy
Authors
Caroline de Bataille
Vincent Sibaud
Angélique Prioul
Anne Laprie
Emmanuelle Vigarios
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 8/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3899-x

Other articles of this Issue 8/2018

Supportive Care in Cancer 8/2018 Go to the issue

Original Article

The effects of high-dose calcitriol and individualized exercise on bone metabolism in breast cancer survivors on hormonal therapy: a phase II feasibility trial

Original Article

Spiritual well-being associated with personality traits and quality of life in family caregivers of cancer patients

Commentary

Conventional versus pigtail chest tube—are they similar for treatment of malignant pleural effusions?

Original Article

Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma

Original Article

Relationship among symptom clusters, quality of life, and treatment-specific optimism in patients with cancer

Original Article

Use of compression garments by women with lymphoedema secondary to breast cancer treatment
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits